We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Anpario Plc | LSE:ANP | London | Ordinary Share | GB00B3NWT178 | ORD 23P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 1.32% | 385.00 | 380.00 | 390.00 | 387.50 | 380.00 | 380.00 | 89,737 | 15:06:51 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pesticides, Agric Chems, Nec | 31M | 2.53M | 0.1241 | 31.02 | 77.38M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/4/2023 16:44 | Welcome earwacks.. See my posts no.1430 and 1434 - all your points made. You are quite correct a 1% drop in revenue does not equate to the carnage we have in the share price. What worries me right now is that we are very vulnerable to a predatory bid. I thought they were vulnerable at 600p let alone below 200p. If a potential acquirer was thinking about making a move then now is the perfect time for them. Don't look a gift horse and all that.. | cfro | |
03/4/2023 16:24 | 1 percent drop in revenue does not equate to 60 percent drop in share price. 25 percent drop in profit due to raw material cost inflation can and will be addressed. The ending of lock down in China and improved trading in Asia and potential in Americas more than off sets decline in bloody brexit Europe. absolute bargain at £1.89. Very grateful to be back in after a lot of patience and a long absence thanks to the absurdity of this market | earwacks | |
28/3/2023 08:24 | Not sure what Mr Market prefers (whisky, hot chocolate, prescription medicine and/or a hug?), but he must be feeling terrible at the moment, so please take good care of him if you come across him. Yes, I just took advantage by topping up. No idea where the share price will go short term, and H1 results will probably be weak given the market turmoil (organic acid prices, volume decline), but in a couple of years I suspect 214p will look good. | vprt | |
28/3/2023 06:17 | Good to see both the CFO and CEO purchase shares down here. Still awaiting the Chairwoman however. | cfro | |
27/3/2023 10:34 | Wasn’t me. I’ve never down liked a post. Different opinions are what make a market. | wjccghcc | |
26/3/2023 08:54 | You don't go round adjusting everything for inflation though. Don't forget every country has differing inflation rates that change constantly. If you did that you would just get yourself in such a tizz. By the sounds of it your opinion certainly isn't mine which is quite the opposite in fact. (Edit - i wonder whom gave the down-like Lol...) | cfro | |
26/3/2023 08:14 | Yes but revenues will be quite a bit lower when adjusted for inflation. It does seem they’re going backwards in real terms. | wjccghcc | |
25/3/2023 10:42 | Thought i would spend some time going through past years results (going back a few years) to be reminded of the sorts of figures the company was reporting way back when. Interesting to do a comparison between then and now: The financial year 2014 stood out due to it's similar basic earning per share number of 15.6p for that year. The revenues for that particular FY was £26.6m (a gain of only £0.6m from the year before despite favourable FX that year). The net cash stood at £6.6m and the dividend was 4.5p. Fast forward to today and we have eps about the same at 16p. Revenues now stand at £33.1m. Net cash of £13.6m (around 25% of market cap) and dividend of 7.35p. Hence decidedly better numbers all round from what the company was achieving back then (despite the profit warning). ...However, and this is the interesting bit, at the time the fy2014 results were published on March 4th 2015 the share price stood at 305p... | cfro | |
23/3/2023 10:03 | That was one of the points i was making in my post above, with China re-opening it is quite obvious we will see quite possibly some really explosive growth come through. | cfro | |
23/3/2023 09:42 | Interesting to see EAH group are starting to see a recovery in Asia, their main business is antibiotics for pigs in China. Good to see this market place showing signs of life.. | igoe104 | |
23/3/2023 09:39 | Just FYI, group revenues were probably down 3-4% in constant currency terms Appreciate the broader point. The stock just wasn't/isn't cheap though to allow investors to look through disappointments; quite far from it Eric | pireric | |
23/3/2023 09:23 | I said it yesterday but the key figure in the results is the revenues. They were only down by 1% to £33.1 from £33.4m in 2021. That is nothing in the great scheme of things and many seem to forget that last years sales were record breaking at that.. Far too many investors are focusing on the bottom line where margins have been squeezed. The company has such a diversified geographical spread that if one region is down another can be up, hence no reason as to why we cannot see higher margins once more. Two extremely important regions are China and America. The former down by -6% was obviously hit by the covid lockdown restrictions. Not a lot could be done about that from the companies point of view but they are now re-opening and therefore no reason not expect growth in that region to really accelerate perhaps even seeing triple digit growth figures next year? America grew by +19%. It is another important growth area for the company, with a lot to go for and is increasingly being recognised there too (to the extent any future bid could come from there?). The UK was a major drag down by -36% due to loss of a major client. A turnaround here in the home market would make all the difference. | cfro | |
22/3/2023 23:06 | Sceptical , why would you add if you think this is a dead cat bounce? | wad collector | |
22/3/2023 16:20 | "some time end of march" that certainly doesn't leave long cfro. Could you offer a link to that infomation please. I'm not a current shareholder but have been in the past but may buy a few shares just to look round the place. 3800 | 3800 | |
22/3/2023 15:32 | cerrito/somerset lad, I believe there is to be a shareholder get together and tour of the new facilities some time end of march (not sure exact date). Open to all. A perfect opportunity to meet the directors and ask questions. Otherwise Richard Edwards is very approachable either by phone or email for any questions you may have. | cfro | |
22/3/2023 14:07 | Somerset lad Fair enough question and too bad they have apart from the AGM no set piece chances to engage with management like an IMC event. | cerrito | |
22/3/2023 13:36 | Got a few k at 214. Lets see where this dog takes us | scepticalinvestor | |
22/3/2023 13:12 | On the bright side, might dip my toe in for the inevitable dead cat bounce. | scepticalinvestor | |
22/3/2023 11:33 | I wonder whether they need to reverse the decision to shift to direct sales, since their turnover is small and spread across so many geographies, products and types of farming. | somerset lad | |
22/3/2023 11:18 | I sold too, and I was in this for the long term. That outlook statement was about as miserable as I’ve seen. A shame, as I really like the company. | jockthescot75 | |
22/3/2023 11:05 | pireric I concur. It is clear that the directors had predicted a recovery in the first few months of the year. the issue is what PE can you value the shares on. I sold this morning at 250 taking a £7K loss having realised what the forecast might be. I tried to warn others. I am not a shorter. | zipstuck | |
22/3/2023 10:51 | 2023 EPS estimate from Peel Hunt today is only a fraction above 11p Eric | pireric | |
22/3/2023 09:24 | That's all he does, he looks at the worst performing stocks on the day and posts the same comments every day... Hes a very sad individual... | igoe104 | |
22/3/2023 09:19 | ScepticalInvestor, What ignorant, uneducated and down-right rude comments to make. Just shows what a horrible person you are in real life... | cfro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions